| No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting JE Volk, JL Marcus, T Phengrasamy, D Blechinger, DP Nguyen, ... Clinical infectious diseases 61 (10), 1601-1603, 2015 | 602 | 2015 |
| Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care JL Marcus, CR Chao, WA Leyden, L Xu, CP Quesenberry Jr, DB Klein, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 73 (1), 39-46, 2016 | 480 | 2016 |
| Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016 JL Marcus, WA Leyden, SE Alexeeff, AN Anderson, RC Hechter, H Hu, ... JAMA network open 3 (6), e207954-e207954, 2020 | 465 | 2020 |
| Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion KT Bernstein, JL Marcus, G Nieri, SS Philip, JD Klausner JAIDS Journal of Acquired Immune Deficiency Syndromes 53 (4), 537-543, 2010 | 441 | 2010 |
| Preexposure prophylaxis for HIV prevention in a large integrated health care system: adherence, renal safety, and discontinuation JL Marcus, LB Hurley, CB Hare, DP Nguyen, T Phengrasamy, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 73 (5), 540-546, 2016 | 315 | 2016 |
| No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis JL Marcus, DV Glidden, KH Mayer, AY Liu, SP Buchbinder, KR Amico, ... PloS one 8 (12), e81997, 2013 | 305 | 2013 |
| SARS-CoV-2 transmission dynamics should inform policy M Cevik, JL Marcus, C Buckee, TC Smith Clinical Infectious Diseases, 2020 | 221* | 2020 |
| HIV infection and incidence of ischemic stroke JL Marcus, WA Leyden, CR Chao, FC Chow, MA Horberg, LB Hurley, ... Aids 28 (13), 1911-1919, 2014 | 146 | 2014 |
| Risk perception, sexual behaviors, and PrEP adherence among substance-using men who have sex with men: a qualitative study ED Storholm, JE Volk, JL Marcus, MJ Silverberg, DD Satre Prevention Science 18, 737-747, 2017 | 145 | 2017 |
| Use of electronic health record data and machine learning to identify candidates for HIV pre-exposure prophylaxis: a modelling study JL Marcus, LB Hurley, DS Krakower, S Alexeeff, MJ Silverberg, JE Volk The lancet HIV 6 (10), e688-e695, 2019 | 143 | 2019 |
| Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care DB Klein, WA Leyden, L Xu, CR Chao, MA Horberg, WJ Towner, ... Clinical infectious diseases 60 (8), 1278-1280, 2015 | 136 | 2015 |
| Use of abacavir and risk of cardiovascular disease among HIV-infected individuals JL Marcus, RS Neugebauer, WA Leyden, CR Chao, L Xu, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 71 (4), 413-419, 2016 | 119 | 2016 |
| Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men JL Marcus, KT Bernstein, RP Kohn, S Liska, SS Philip Sexually transmitted diseases 38 (10), 922-924, 2011 | 119 | 2011 |
| Survival among HIV-Infected and HIV-Uninfected Individuals with Common Non–AIDS-Defining Cancers JL Marcus, C Chao, WA Leyden, L Xu, J Yu, MA Horberg, D Klein, ... Cancer Epidemiology, Biomarkers & Prevention 24 (8), 1167-1173, 2015 | 118 | 2015 |
| Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection KR Amico, JL Marcus, V McMahan, A Liu, KA Koester, P Goicochea, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 66 (5), 530-537, 2014 | 104 | 2014 |
| Helping our patients take HIV pre‐exposure prophylaxis (PrEP): a systematic review of adherence interventions JL Marcus, T Buisker, T Horvath, KR Amico, JD Fuchs, SP Buchbinder, ... HIV medicine 15 (7), 385-395, 2014 | 103 | 2014 |
| Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care D Krakower, KM Maloney, VE Powell, K Levine, C Grasso, K Melbourne, ... Journal of the International AIDS Society 22 (2), e25250, 2019 | 100 | 2019 |
| Successful implementation of HIV preexposure prophylaxis: lessons learned from three clinical settings JL Marcus, JE Volk, J Pinder, AY Liu, O Bacon, CB Hare, SE Cohen Current HIV/AIDS Reports 13, 116-124, 2016 | 100 | 2016 |
| Artificial intelligence and machine learning for HIV prevention: emerging approaches to ending the epidemic JL Marcus, WC Sewell, LB Balzer, DS Krakower Current HIV/AIDS Reports 17, 171-179, 2020 | 88 | 2020 |
| Perceived interruptions to HIV prevention and treatment services associated with COVID-19 for gay, bisexual, and other men who have sex with men in 20 countries A Rao, K Rucinski, BA Jarrett, B Ackerman, S Wallach, J Marcus, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 87 (1), 644-651, 2021 | 83 | 2021 |
Michael SilverbergVerified email at kp.org